New York University Medical Oncology Associates — New York, New York

New York University Medical Oncology Associates is a clinical research site located in New York, New York, United States 10016.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

New York University Medical Oncology Associates has participated in 4 clinical trials with 2 currently active.

Therapeutic areas: HER2-positive Breast Cancer, HER2-positive Gastric Cancer, HER2-positive Non-Small Cell Lung Cancer.

Sponsors: Mersana Therapeutics, Denovo Biopharma LLC, Arcus Biosciences, Inc..

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York University Medical Oncology Associates?

New York University Medical Oncology Associates has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York University Medical Oncology Associates conducted?

New York University Medical Oncology Associates has 4 clinical trials on record, with 2 currently active. Their work covers HER2-positive Breast Cancer, HER2-positive Gastric Cancer, HER2-positive Non-Small Cell Lung Cancer.

Is New York University Medical Oncology Associates accredited by Crixeo Health?

Yes — New York University Medical Oncology Associates holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about New York University Medical Oncology Associates?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.